{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:54:39Z","timestamp":1753890879957,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Dyslipidaemia represents a group of disorders of lipid metabolism, characterized by either an increase or decrease in lipid particles, usually associated with triglycerides, LDL cholesterol (LDL-C) and\/or HDL cholesterol (HDL-C). Most hyperlipidaemias and HDL deficiencies confer an increased cardiovascular risk, while hypolipidaemia, such as abeta or hypobetalipoproteinemia, may present different manifestations ranging from poor weight progression to neurological manifestations. The aim of this study is to present 7 cases with rare dyslipidaemias associated with low LDL or low HDL cholesterol values, referred to our laboratory for the genetic identification of the cause of the dyslipidaemia.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Lipid profile was determined for each individual in an automated equipment Integra Cobas (Roche). Molecular analysis was performed by NGS with a target panel of 57 genes involved in lipid metabolism (Sure select QXT, Agilent) and samples were run in a NextSEQ Sequencer (Illumina). Only genes associated to rare forms of low HDL-c or LDL-c were analysed for this work, namely: <jats:italic>ABCA1<\/jats:italic>, <jats:italic>APOA1<\/jats:italic>, <jats:italic>LCAT, SCARB1, APOB, PCSK9, MTTP, SAR1B, and ANGPTL3<\/jats:italic>. All rare variants (MAF&amp;lt;5%) found in these genes were confirmed by Sanger sequencing.<\/jats:p><jats:p><jats:bold>Results and discussion:<\/jats:bold> This study includes 7 index cases (IC), with the following clinical diagnoses: Fish Eye Disease (1), Hypoalphalipoproteinemia (1) and Abetalipoproteinemia (ABL) \/ Familial Hypobetalipoproteinemia (FHBL) (5). We have identified one IC with a compound heterozygosity in <jats:italic>LCAT<\/jats:italic> causing Fish Eye Disease and one IC with a variant in <jats:italic>ABCA1<\/jats:italic> in homozygosity causing Tangier disease. We found variants causing homozygous FHBL in 2 IC, one of whom has an undescribed pathogenic variant in homozygosity in <jats:italic>APOB<\/jats:italic> (c.12087+1G&amp;gt;A) and the other is a possible compound heterozygous for <jats:italic>APOB<\/jats:italic> variants c.2604+1G&amp;gt;A and c.4651C&amp;gt;T\/p.(Gln1551*). In two patients only a variant in heterozygosity (c.3365delG\/p.(Gly1122Vfs*62) and c.11095A&amp;gt;T\/p.(Arg3699*)). In the remaining patient, no variants were identified. NGS proved to be a fundamental key for genetic testing of rare lipid disorders, allowing us to find the genetic cause of disease in 6\/7 patients with low HDL-c and LDL-c. Patients with these rare conditions should be identified as early as possible in order to minimize or prevent clinical manifestations. The unsolved case is still under investigation.<\/jats:p>","DOI":"10.3389\/fgene.2022.1088040","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T10:44:50Z","timestamp":1681728290000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Rare primary dyslipidaemias associated with low LDL and HDL cholesterol values in Portugal"],"prefix":"10.3389","volume":"13","author":[{"given":"Ana Catarina","family":"Alves","sequence":"first","affiliation":[]},{"given":"Beatriz","family":"Miranda","sequence":"additional","affiliation":[]},{"given":"Oana","family":"Moldovan","sequence":"additional","affiliation":[]},{"given":"Raquel Esp\u00edrito","family":"Santo","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Gouveia Silva","sequence":"additional","affiliation":[]},{"given":"Sandra","family":"Soares Cardoso","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa","family":"Diogo","sequence":"additional","affiliation":[]},{"given":"M\u00f3nica","family":"Seidi","sequence":"additional","affiliation":[]},{"given":"Silvia","family":"Sequeira","sequence":"additional","affiliation":[]},{"given":"Mafalda","family":"Bourbon","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/J.CELL.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Ally","year":"2017","journal-title":"Cell"},{"key":"B2","first-page":"303","article-title":"Tangier disease","volume-title":"Am. J. Cardiovasc. Drugs","author":"Alshaikhli","year":"2012"},{"volume-title":"Tangier disease","year":"2019","author":"Burnett","key":"B3"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/(sici)1098-1004(200001)15:1<7::aid-humu4>3.0.co;2-n","article-title":"Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion","volume":"15","author":"Dunnen","year":"2000","journal-title":"Hum. Mutat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-6-1","article-title":"Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson\u2019s disease (chylomicron retention disease)","volume":"6","author":"Georges","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-383834-6.00100-2","article-title":"Chapter 96-Lipoprotein and lipid metabolism","author":"Hegele","year":"2013","journal-title":"Emery Rimoin\u2019s Princ. Pract. Med. Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: A European atherosclerosis society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet. Diabetes Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/10408360500295113","article-title":"Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism","volume":"42","author":"Hooper","year":"2005","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/s0022-2275(20)41964-9","article-title":"ApoB gene nonsense and splicing mutations in a compound heterozygote for familial hypobetalipoproteinemia","volume":"32","author":"Huang","year":"1991","journal-title":"J. Lipid Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4103\/0971-4065.179304","article-title":"Secret in the eyes - fish eye disease","volume":"26","author":"Ingle","year":"2016","journal-title":"Indian J. Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"531210","DOI":"10.1101\/531210","article-title":"Variation across 141, 456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes","author":"Karczewski","year":"2019","journal-title":"BioRxiv"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/J.AJHG.2014.01.010","article-title":"Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol","volume":"94","author":"Lange","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S12276-018-0174-2","article-title":"Clinical significance of APOB inactivation in hepatocellular carcinoma","volume":"50","author":"Lee","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10545-013-9665-4","article-title":"Abetalipoproteinemia and homozygous hypobetalipoproteinemia: A Framework for diagnosis and management","volume":"37","author":"Lee","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/MOL.0000000000000578","article-title":"Chylomicron retention disease: Genetics, biochemistry, and clinical spectrum","volume":"30","author":"Levy","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbalip.2008.01.003","article-title":"PCSK9: An enigmatic protease","volume":"1781","author":"Lopez","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"B19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/CGE.13250","article-title":"Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy","volume":"94","author":"Marmontel","year":"2018","journal-title":"Clin. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/J.GENE.2013.08.049","article-title":"Familial hypobetalipoproteinemia: Analysis of three Spanish cases with two new mutations in the APOB gene","volume":"531","author":"Mart\u00edn-Morales","year":"2013","journal-title":"Gene"},{"key":"B21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/157016111794519354","article-title":"Hypocholesterolemia","volume":"9","author":"Moutzouri","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1172\/JCI115799","article-title":"Lipoproteins containing the truncated apolipoprotein, apo B-89, are cleared from human plasma more rapidly than apo B-100-Containing lipoproteins in vivo","volume":"89","author":"Parhofer","year":"1992","journal-title":"J. Clin. ."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1194\/JLR.P120000976","article-title":"Progression of chronic kidney disease in familial LCAT deficiency: A follow-up of the Italian cohort","volume":"61","author":"Pavanello","year":"2020","journal-title":"J. Lipid Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1038\/S41598-019-39998-2","article-title":"Rare pathogenic variants predispose to hepatocellular carcinoma in nonalcoholic fatty liver disease","volume":"9","author":"Pelusi","year":"2019","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.jacl.2019.09.003","article-title":"In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia","volume":"13","author":"Rabacchi","year":"2019","journal-title":"J. Clin. Lipidol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cca.2015.10.033","article-title":"Update on the molecular biology of dyslipidemias","volume":"454","author":"Ramasamy","year":"2016","journal-title":"Clin. Chim. Acta."},{"key":"B27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1161\/01.ATV.0000176191.64314.07","article-title":"Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia","volume":"25","author":"Sankatsing","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"volume-title":"Lecithin cholesterol acyltransferase deficiency and fish eye disease | the online metabolic and molecular bases of inherited disease | OMMBID | McGraw Hill medical","year":"1998","author":"Santamarina-Fojo","key":"B29"},{"key":"B30","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.atherosclerosis.2007.08.017","article-title":"Non-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiography","volume":"197","author":"Santos","year":"2008","journal-title":"Atherosclerosis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/J.PCAD.2016.08.006","article-title":"Diagnosis and treatment of high density lipoprotein deficiency","volume":"59","author":"Schaefer","year":"2016","journal-title":"Prog. Cardiovasc. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature24286","article-title":"DNA sequencing at 40: Past, present and future","volume":"550","author":"Shendure","year":"2017","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/APT.14154","article-title":"Editorial: New insights into the relationship between the intestine and non-alcoholic fatty liver-is \u2018fatty gut\u2019 involved in disease progression?","volume":"46","author":"Valenti","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/S11886-017-0940-0","article-title":"HDL cholesterol metabolism and the risk of CHD: New insights from human genetics","volume":"19","author":"Vitali","year":"2017","journal-title":"Curr. Cardiol. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1126\/science.1439810","article-title":"Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia","volume":"258","author":"Wetterau","year":"1992","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/nprot.2015.105","article-title":"Genomic variant annotation and prioritization with ANNOVAR and WANNOVAR","volume":"10","author":"Yang","year":"2015","journal-title":"Nat. Protoc."},{"key":"B37","first-page":"63","article-title":"Braunwald\u2019s heart disease: A textbook of cardiovascular medicine, 11th edition","volume":"5","author":"Zipes","year":"2018","journal-title":"BMH Med. J."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1088040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T10:44:54Z","timestamp":1681728294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.1088040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":37,"alternative-id":["10.3389\/fgene.2022.1088040"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.1088040","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"article-number":"1088040"}}